Filing Flows › Steris (STE) › Q3 FY26
Steris (STE) Q3 FY26 earnings results (third quarter fiscal 2026)
10-Q filed Feb 6, 2026
Steris (STE) reported revenue of $1.5B for the third quarter fiscal 2026 (Q3 FY26), +9% from a year earlier and +2% from the quarter before. Operating margin was 18.3%, net earnings $194M (13.0% of revenue).
Steris, Q3 FY26: revenue $1.5B (+9% year over year), operating margin 18.3%, net earnings $194M, operating cash flow $298M. The chart follows the revenue to costs, profit and cash.
| Q3 FY26 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.5B | +2% | +9% |
| Gross profit | $656M | +1% | +7% |
| Operating profit | $273M | +3% | +11% |
| Net earnings | $194M | +0.9% | +12% |
| Operating cash flow | $298M | +4% | -10% |
| Free cash flow | $200M | -0.9% | -18% |
What changed
Revenue was $1.5B in Q3 FY26, up 9% year over year and up 2% from the previous quarter. Healthcare was the largest line at 71% of revenue. Healthcare added $0.09B year over year (up 9%), 70% of the total change.
Gross margin was 43.8%, down 0.7 points from a year earlier. Operating profit was $0.27B, a 18.3% margin (up 0.4 points year over year). Of the extra revenue versus a year earlier, 22% reached operating profit, above the 18% margin then. Operating expenses grew 5% against revenue growth of 9%. Net earnings were $0.19B, up 11% year over year. The effective tax rate was 24.6%.
Operating cash flow was $0.30B (down 10% year over year), 153% of net earnings. Non-cash charges added back $0.12B of depreciation and amortization and $0.02B of share-based compensation. Working capital and other items used $0.03B. Capital expenditures of $0.10B left free cash flow of $0.20B.
Questions
What was Steris' revenue in the third quarter fiscal 2026?
Steris (STE) reported revenue of $1.5B for the third quarter fiscal 2026 (Q3 FY26), +9% from a year earlier and +2% from the quarter before.
Was Steris profitable in the third quarter fiscal 2026?
Operating profit was $273M (18.3% of revenue) and net earnings $194M.
Source: Steris 10-Q on SEC EDGAR.